University of Virginia Health System tests new device for mitral valve disease
The mitral valve is an essential part of your heart. Matter of fact, you wouldnt exist without it. The valve is essentially a small, round hole with two flaps on the top and bottom. Its job is to open and close rapidly, regulating the flow of blood between the upper and lower chambers of the hearts left side- the main pumping chambers that send oxygen-rich red blood to your limbs and organs.
In some people, however, the mitral valve can leak, usually because of a congenital deformity or after a serious heart attack when the heart muscle itself is damaged. "Significant leakage of the mitral valve can shorten someones life, not to mention making it tough to go about the activities of daily living," said Dr Scott Lim, a cardiologist at the University of Virginia Health System.
For years, the standard of care for mitral valve leakage has been open-heart surgery with the patient on a bypass machine. Now, heart patients at the UVa Health System have a new, less invasive, option to get a leaky valve fixed.
The UVa Health System is part of a national, randomized clinical trial of a tiny, permanent, implanted device made out of titanium called the MitraClip, which ‘clips the leaky halves of the mitral valve together without major surgery. The MitraClip procedure starts with a catheter in a patients leg vein. The catheter, with the clip inside, is gently threaded to the heart to the part of the mitral valve that is leaking the most. Doctors then repair the valve via the catheter by putting the MitraClip clip on it with special hooks.
"The obvious advantage is that this is less invasive than open-heart surgery and patients can heal quicker," Lim said. "The procedure is done on an outpatient basis with an overnight observation. Patients can go home the very next day with no pain from open chest surgery."
Lim is the principal investigator at UVa for the trial, called EVEREST 2. He said the trial should help doctors know if the mitral valve clip is as effective as standard open- heart surgery. "We think this is as safe or safer but part of the purpose of the trial is to determine that for sure. So far, in 49 patients around the U.S. there have been no major life-threatening complications," Lim said.
General criteria for patients to be included in the trial are: over age 18 with significant mitral valve leakage and a candidate for mitral valve surgery. Patients in the study are randomized to either the MitraClip device or mitral valve surgery at UVa, and are required to have follow-up at set intervals at UVa for the study duration. For more information on the EVEREST 2 trial at UVa, contact Dr Scott Lim at (434) 924-9119 or Linda Bailes, RN, at (434) 982-1058.
Bob Beard | EurekAlert!
The most recent press releases about innovation >>>
Die letzten 5 Focus-News des innovations-reports im Überblick:
HZI researchers developed a bacterial strain that can be used in cancer therapy
Salmonellae are dangerous pathogens that enter the body via contaminated food and can cause severe infections. But these bacteria are also known to target...
University of Maryland researchers contribute to historic detection of gravitational waves and light created by event
On August 17, 2017, at 12:41:04 UTC, scientists made the first direct observation of a merger between two neutron stars--the dense, collapsed cores that remain...
Seven new papers describe the first-ever detection of light from a gravitational wave source. The event, caused by two neutron stars colliding and merging together, was dubbed GW170817 because it sent ripples through space-time that reached Earth on 2017 August 17. Around the world, hundreds of excited astronomers mobilized quickly and were able to observe the event using numerous telescopes, providing a wealth of new data.
Previous detections of gravitational waves have all involved the merger of two black holes, a feat that won the 2017 Nobel Prize in Physics earlier this month....
Material defects in end products can quickly result in failures in many areas of industry, and have a massive impact on the safe use of their products. This is why, in the field of quality assurance, intelligent, nondestructive sensor systems play a key role. They allow testing components and parts in a rapid and cost-efficient manner without destroying the actual product or changing its surface. Experts from the Fraunhofer IZFP in Saarbrücken will be presenting two exhibits at the Blechexpo in Stuttgart from 7–10 November 2017 that allow fast, reliable, and automated characterization of materials and detection of defects (Hall 5, Booth 5306).
When quality testing uses time-consuming destructive test methods, it can result in enormous costs due to damaging or destroying the products. And given that...
Using a new cooling technique MPQ scientists succeed at observing collisions in a dense beam of cold and slow dipolar molecules.
How do chemical reactions proceed at extremely low temperatures? The answer requires the investigation of molecular samples that are cold, dense, and slow at...